Simplex Trading’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,159
| Closed | -$52K | – | 8323 |
|
|
2019
Q2 | $52K | Sell |
10,159
-13,315
| -57% | -$59.8K | ﹤0.01% | 4835 |
|
|
2019
Q1 | $84K | Buy |
23,474
+22,837
| +3,585% | +$99K | ﹤0.01% | 4538 |
|
|
2018
Q4 | $3K | Buy |
+637
| New | +$3.89K | ﹤0.01% | 6506 |
|
|
2018
Q3 | – | Sell |
-6,686
| Closed | -$33.4K | – | 8484 |
|
|
2018
Q2 | $28K | Sell |
6,686
-5,989
| -47% | -$30.2K | ﹤0.01% | 5606 |
|
|
2018
Q1 | $55K | Buy |
12,675
+9,371
| +284% | +$41.8K | ﹤0.01% | 2349 |
|
|
2017
Q4 | $17K | Sell |
3,304
-6,456
| -66% | -$39.5K | ﹤0.01% | 3480 |
|
|
2017
Q3 | $59K | Buy |
+9,760
| New | +$61.8K | ﹤0.01% | 2160 |
|
|
2017
Q2 | – | Sell |
-3,951
| Closed | -$24.3K | – | 7204 |
|
|
2017
Q1 | $20K | Buy |
+3,951
| New | +$26.7K | ﹤0.01% | 3281 |
|
|
2016
Q3 | – | Sell |
-7,163
| Closed | -$59.5K | – | 6833 |
|
|
2016
Q2 | $45K | Buy |
+7,163
| New | +$46.1K | ﹤0.01% | 2173 |
|
|
2016
Q1 | – | Sell |
-54
| Closed | -$203 | – | 6648 |
|
|
2015
Q4 | $0 | Buy |
+54
| New | +$357 | ﹤0.01% | 6505 |
|
|
2015
Q2 | – | Sell |
-2,111
| Closed | -$30.5K | – | 6183 |
|
|
2015
Q1 | $33K | Buy |
+2,111
| New | +$37.6K | ﹤0.01% | 1890 |
|
Other funds holding PETX
Simplex Trading's PETX Position: Q3 2019 in Review
Simplex Trading sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 10,159 shares — an estimated $52K sold.
Simplex Trading first reported a position in PETX in Q1 2015 and held it in 11 quarters. The position peaked at $84K in Q1 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Simplex Trading reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Simplex Trading sold 10,159 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $52K.
- Simplex Trading first reported a position in Aratana Therapeutics, Inc. in Q1 2015 and held it in 11 quarters.
- Simplex Trading's Aratana Therapeutics, Inc. position peaked at $84K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.